ARS Pharmaceuticals, Inc. SPRY
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Josh Schimmer | Cantor Fitzgerald | 14.24 $ | 30 $ | 15.76 % | 19/08/2024 |
| Strong Buy | Raymond James | 10.85 $ | 22 $ | 11.15 % | 12/08/2024 |
| Ryan Deschner | Raymond James | 10.4 $ | 18 $ | 7.60 % | 25/07/2024 |
| Roanna Ruiz | Leerink Partners | 8.65 $ | 18 $ | 9.35 % | 05/03/2024 |